Dry AMD

20 Years of CIRM: The evolution of a CIRM-funded therapy for macular degeneration

/ California Institute for Regenerative Medicine (CIRM) / 1 Comment

Image Credit: University of Southern California (USC) Eye Institute In celebration of CIRM’s 20th anniversary, we are reflecting on some of the early projects we supported that have since advanced to clinical trials.  One such trial for a form of blindness originated with a 2007 SEED grant to David Hinton, MD, of the University of … Continue reading 20 Years of CIRM: The evolution of a CIRM-funded therapy for macular degeneration

FDA Grants RMAT Designation to Luxa Biotechnology’s CIRM-funded Dry AMD Therapy 

/ California Institute for Regenerative Medicine (CIRM) / 1 Comment

Credit: Shutterstock The FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation for a project focused on vision loss that was funded in part by the California Institute for Regenerative Medicine (CIRM). This designation is given to highly promising regenerative medicine therapies that treat serious or life-threatening diseases with the goal of accelerating the path … Continue reading FDA Grants RMAT Designation to Luxa Biotechnology’s CIRM-funded Dry AMD Therapy